Studies from Conception Hospital in the Area of Contraception Described

By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators publish new report on Reproductive Medicine - Contraception. According to news reporting originating in Marseille, France, by NewsRx journalists, research stated, "To assess the effectiveness and costs associated with contraceptive methods based on real world data in France. A cross-sectional cohort study based on data from a representative sample of the French National Healthcare Insurance Database(Echantillon Generalistes des Benefidaires(EGB))was performed between January 1st 2006 and December 31st 2012."

Financial support for this research came from MSD France (see also Reproductive Medicine - Contraception).

The news reporters obtained a quote from the research from Conception Hospital, "Women aged 15 years or older and users of at least one reimbursed contraceptive method between January 1st 2012 and December 31st 2012 were selected. The outcome of interest was unintended pregnancy, defined as pregnancies occurring after at least one month since the dispensation of a contraceptive method. The mean annual costs of contraceptive methods (in 2012 Euros) were collected in the database from a health system perspective. Costs were expressed for the first year of use, considering the next years of use and taking into account or not the cost of unplanned pregnancies. A population of 48,090 women representative of the 4,664,730 French women with a reimbursed contraceptive method was identified in the EGB in 2012: 68.6% used at least one reimbursed oral contraception (OC), 30.2% used at least one intrauterine devices (IUD)(LGN-1US 52 mg,17.6%; copper,13.1%) and 5.1% used at least one etonogestrel implant. Unplanned pregnancies rates ranged from 0.6% with LNG-IUS 52 mg and 0.8% with the etonogestrel implant to 4.8% with 1st and 2nd generation combined OCs. The mean annual costs of contraception for the first year of use ranged from (sic)145 for 1st-2nd generation combined oral contraceptions (COCs) to (sic)308 for LNG-IUS 52 mg taking into account the next years of use, the etonogestrel implant was associated with the lowest mean annual cost( 88). When costs of unplanned pregnancies were taken into account, the mean annual cost of contraception for the first year of use was lower for progestin-only OC ((sic)251) and copper IUD ((sic)257) compared to etonogestrel implant ((sic)300) and LNG-IUS 52 mg((sic)323)."

According to the news reporters, the research concluded: "This real-world study suggests that Long-acting reversible contraceptives (LARCs) (i.e. implant and IUDs)should be considered fora broader use to prevent unplanned pregnancies and related abortions in France both from a public health and economic perspective."

For more information on this research see: Effectiveness and cost of contraception in France (FACET study): a cohort study from the French National Healthcare Insurance Database. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2018;229():137-143. European Journal of Obstetrics & Gynecology and Reproductive Biology can be contacted at: Elsevier Science Bv, PO Box 211, 1000 Ae Amsterdam, Netherlands. (Elsevier - www.elsevier.com; European Journal of Obstetrics & Gynecology and Reproductive Biology - www.journals.elsevier.com/european-journal-of-obstetrics-and-gynecology-and-reproductive-biology/)

Our news correspondents report that additional information may be obtained by contacting A. Agostinia, Hopital Conception, Serv Gynecol Obstet, F-13005 Marseille, France. Additional authors for this research include C. Godard, C. Laurendeau, A. Benmahmoud, A. Lafuma, M. Doe, L. Levy-Bachelot, J. Gourmelen and T. Linete.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1016/j.ejogrb.2018.08.007. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)